Grace Therapeutics, INC. (GRCE) — DEF 14A Filings
All DEF 14A filings from Grace Therapeutics, INC.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Grace Therapeutics Sets Virtual Annual Meeting for Sept. 12
— Jul 28, 2025 Risk: low
Grace Therapeutics, Inc. (GRCE) has filed a definitive proxy statement (DEF 14A) for its 2025 Annual Meeting of Stockholders, scheduled virtually for September
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX